Neutropenia in Preterm Infants

Curr Pediatr Rev. 2023;19(4):352-356. doi: 10.2174/1573396319666221216121530.

Abstract

Background: The non-specific and antigen-specific components of host defense mechanisms are subject to the adaptation process in the neonate; however, the neutrophil quantitative and qualitative deficiency is one of the most significant causative factors of neonatal-increased vulnerability to infection.

Objective: To review the incidence and outcome of neutropenia of unknown cause in preterm infants.

Results: The incidence of early and late-onset idiopathic neutropenia of prematurity is significant.

Conclusion: The low neutrophil counts respond quickly to G-CSF treatment; however, due to the low probability of septic complications, particularly in the late-onset neutropenia, a deep diagnostic approach and the potential hematopoietic growth factor treatment should be limited to the severe cases, such as a neutrophil count <500/μL, lasting for more than 2 days.

Keywords: Neutropenia; early and late-onset; hematopoietic growth factors; neonatal; prematurity; sepsis.

MeSH terms

  • Granulocyte Colony-Stimulating Factor / therapeutic use
  • Humans
  • Infant, Newborn
  • Infant, Premature*
  • Leukocyte Count
  • Neutropenia* / diagnosis
  • Neutropenia* / etiology
  • Neutropenia* / therapy
  • Neutrophils

Substances

  • Granulocyte Colony-Stimulating Factor